Page last updated: 2024-11-06

triphenylmethylphosphonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Triphenylmethylphosphonium (TPP) is a cationic organophosphorus compound. It is commonly synthesized by reacting triphenylphosphine with a suitable alkylating agent, such as methyl iodide. TPP exhibits interesting properties, including its ability to act as a Lewis acid and its role in various chemical reactions. Its strong electron-withdrawing nature makes it a valuable reagent in organic synthesis, particularly in reactions involving nucleophiles. TPP has also been studied for its potential applications in catalysis, materials science, and biological systems. Its importance lies in its versatility and ability to participate in various chemical transformations.'

triphenylmethylphosphonium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74506
CHEMBL ID1179021
SCHEMBL ID8952
MeSH IDM0057938

Synonyms (23)

Synonym
AKOS005431509
methyl(triphenyl)phosphonium
STK386899
methyl(triphenyl)phosphanium
methyltriphenylphosphonium
CHEMBL1179021
triphenylmethylphosphonium
unii-05g6u0txs3
phosphonium, methyltriphenyl-
05g6u0txs3 ,
15912-74-0
methyltriphenylphosphonium ion
SCHEMBL8952
methyl triphenylphosphine
LUEHMMBSOBSVGA-UHFFFAOYSA-N
methyl triphenylphosphonium
methyl-triphenyl-phosphonium
AZFQCTBZOPUVOW-UHFFFAOYSA-N
triphenylphosphonium methylide
DTXSID20166591
CS-0183893
triphenylmethylphosphonium cation
b5j ,

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1648020Stimulation of recombinant wild-type human TRAP1 ATPase activity expressed in Escherichia coli BL21 (DE3) up to 20 uM preincubated for 0.5 hrs followed by 2 mM ATP addition and measured after 3 hrs by PiColorLock Gold reagent based colorimetric assay2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug.
AID1648019Stimulation of recombinant wild-type human TRAP1 ATPase activity expressed in Escherichia coli BL21 (DE3) up to 20 uM preincubated for 0.5 hrs followed by 0.2 mM ATP addition and measured after 3 hrs by PiColorLock Gold reagent based colorimetric assay2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (170)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990105 (61.76)18.7374
1990's26 (15.29)18.2507
2000's14 (8.24)29.6817
2010's15 (8.82)24.3611
2020's10 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 14.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index14.52 (24.57)
Research Supply Index5.18 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (14.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (4.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other169 (95.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]